DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 07 · Volume 45 · November 2012 DOI: 10.1055/s-002-23975

Erratum

  • e2
    Gahr, M.; Schmid, M. M.; Schönfeldt-Lecuona, C.:

    Pregabalin-associated Elevation of Clozapine Serum Levels

    • Review

  • 261
    Franz, M.; Ranger, J.; Hanewald, B.; Gallhofer, B.; Lay, B.:

    Influences on Therapist’s Decisions for Neuroleptic Treatment in Schizophrenia: The Role of Characteristics of the Patient and the Physician

    • Original Paper

  • 269
    Morgan, C.J. A.; Duffin, S.; Hunt, S.; Monaghan, L.; Mason, O.; Curran, H. V.:

    Neurocognitive Function and Schizophrenia-Proneness in Individuals Dependent on Ketamine, on High Potency Cannabis (‘Skunk’) or on Cocaine

  • 275
    Sarris, J.; Fava, M.; Schweitzer, I.; Mischoulon, D.:

    St John’s Wort (Hypericum perforatum) versus Sertraline and Placebo in Major Depressive Disorder: Continuation Data from a 26-Week RCT

  • 279
    Okayasu, H.; Ozeki, Y.; Fujii, K.; Takano, Y.; Saeki, Y.; Hori, H.; Horie, M.; Higuchi, T.; Kunugi, H.; Shimoda, K.:

    Pharmacotherapeutic Determinants for QTc Interval Prolongation in Japanese Patients with Mood Disorder

  • 284
    Laux, G.; and the VIVALDI Study Group:

    The Antidepressant Agomelatine in Daily Practice: Results of the Non-Interventional Study VIVALDI

  • 292
    Seemüller, F.; Lewitzka, U.; Bauer, M.; Meyer, S.; Musil, R.; Schennach, R.; Riedel, M.; Doucette, S.; Möller, H.-J.:

    The Relationship of Akathisia with Treatment Emergent Suicidality among Patients with First-Episode Schizophrenia Treated with Haloperidol or Risperidone

    • Letter

  • 297
    Gahr, M.; Schmid, M. M.; Schönfeldt-Lecuona, C.:

    Pregabalin-associated Elevation of Clozapine Serum Levels

  • 299
    Widschwendter, C. G.; Hofer, A.:

    Aripiprazole Use in Early Pregnancy: A Case Report